All results
19 results for biomarkers als
-
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Pts w/ MIBC
The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone. Bladder…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ARCH II
This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives.…
- Ages
- 25 Years - 75 Years
- Sexes
- All
-
Bio-BOOST
BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA)…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Comprehensive Outcomes for After Cancer Health (COACH)
This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have…
- Ages
- 18 Years - N/A
- Sexes
- All
-
EVOLVE
The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid…
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Immunotherapy for Patients With Advanced Kidney Cancer, The PDIGREE Study
This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Magnetic resonance imaging and biomarkers for muscular dystrophy
The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease…
- Ages
- 5 Years - 62 Years
- Sexes
- Male
-
NIH AIM 2 - Low Dose Pioglitazone in NASH
To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic…
- Ages
- 21 Years - 75 Years
- Sexes
- All